Do you offer OEM or ODM services?

Yes, both OEM and ODM services are available with our R&D team.

What are the payment terms?

We accept LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

SOST Supply Berberine HCL Hydrochloride Powder

Name: SOST Supply Berberine HCL Hydrochloride Powder
Brand: Xi an Sost Biotech Co., Ltd.
SKU: 1909275975

Shaanxi, ChinaXi an Sost Biotech Co., Ltd.

US$105.00-115.00

1 kg

Sample price:US$49.00/piece.Request sample

Product profile

Customization

Available

Certification

USDA Organic/EU Organic/ISO/Kosher/Halal/FDA

Assay Method

HPLC

Model NO.

Berberine HCL Hydrochloride Powder

Application Form

Tablet, Capsule

Application

Health Care Products, Medicine

State

Powder

Extract Source

Berberis Aristata

Product Name

SOST Supply Berberine HCL Hydrochloride Powder

Appearance

Pale Yellow Crystalline Powder

Test Method

HPLC

COA

Available

Sample

Free Sample

Stock

In Stock

Shelf Life

24 Months

Transport Package

Aluminum Foil Bag/Drum

Specification

60%,97%,98% (or customized)

Trademark

SOST

Origin

China

Production Capacity

999999kg/year

Key features

Comprehensive Certifications: USDA Organic, EU Organic, ISO, Kosher, Halal, and FDA certified.

High Purity Assay: Assay results reach 98.32%, exceeding the 98% standard.

Free Sample Availability: Free samples are available for testing and evaluation.

In Stock Status: Product is currently in stock for immediate dispatch.

Multi-Application Forms: Suitable for Tablet and Capsule formulations.

Anti-Arrhythmic Effect: Recently discovered potential for treating heart rhythm disorders.

OEM and ODM Services: Custom manufacturing services available with 2 R&D engineers.

Company profile

Xi an Sost Biotech Co., Ltd.

Shaanxi, China

CertifiedBusiness Type: Manufacturer/Factory CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2012-11-01 CertifiedNearest Port: Shanghai PortAverage Response Time: ≤3.00h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryXi'an Sost Biotech Co., Ltd. is identified as a China-based manufacturer and trading company focused on herbal extracts, Chinese medicine raw materials, cosmetic ingredients, healthcare ingredients, food additives, and dietary supplement ingredients. Evidence indicates established production, R&D, sales, purchasing, and quality-control functions, with stated GMP-oriented operations, ISO 9001:2015 certification, multiple production bases, and broad export coverage. However, the records contain conflicting production information: one slice reports three production bases and eight lines, while another reports a 2,990 m² plant and two production lines. The supplier states that it provides pre- and after-sales service and accepts several trade and payment terms, but detailed service performance, customization results, customer references, and financial strength are not sufficiently documented. Monetary figures are omitted.

Supplier typeThe supplier is explicitly classified as a manufacturer and limited company, while another record identifies its business nature as a trading company. Its stated activities include R&D, production, sales, and service of herbal extracts and natural raw materials, so it appears to combine manufacturing and trading functions.

CertificationsThe supplier reports ISO 9001:2015 certification and states that production follows national GMP standards, with GMP-standard factories and 100,000-level clean workshops. ISO certification is explicit; the GMP statements are operational claims rather than a separately named certificate.

After-Sales capabilityThe company explicitly emphasizes before-sales and after-sales service, states that it continuously improves service, and describes service as part of its business operations. However, no evidence gives measurable after-sales performance, service staffing, response times, or documented customer outcomes.

R&D capabilityThe supplier reports an R&D department, research and development of high-purity natural products, biological engineering and natural extraction technology, and an innovation-oriented approach. Nevertheless, only two years of R&D engineer experience are reported, and there is no evidence of patents, new-product records, or quantified R&D achievements.

Production capacityProduction capability is supported by a stated manufacturing plant, natural-extract production activities, GMP-oriented facilities, clean workshops, and product lines covering food, healthcare, cosmetics, and pharmaceutical intermediates. The data are inconsistent: one record states three production bases and eight lines, while another reports a 2,990 m² plant and two lines; quality-control staffing is also reported as fewer than five employees.